CLS is committed to providing the media with timely and accurate information related to California’s life sciences ecosystem. CLS welcomes all media inquiries from news organizations and reporters. Members of the media interested in speaking with CLS opinion leaders on issues of public policy, life sciences innovation, or issues related to the life sciences ecosystem in California, please contact our communication department.

Media Contact: [email protected]

CALIFORNIA LIFE SCIENCES LOOKS BACK ON 2021 HIGHLIGHTS

Dec 17, 2021

As we reflect on the past year, California’s life sciences industry remained resilient amidst the COVID-19 pandemic, demonstrating stability and a clear focus on science to solve the world’s greatest challenges...

Read More

California Life Sciences featured in Big4Bio’s first Pivot Report exploring Diversity, Equity, and Inclusion

Dec 16, 2021

California Life Sciences is proud to be featured in Big4Bio’s first Pivot Report exploring Diversity, Equity, and Inclusion! We share what CLS is doing differently to make real impact, how..

Read More

WATCH: California Life Sciences and Bio Supply Management Alliance talk supply chain in a digital Member Readout

Dec 14, 2021

In this digital Member Readout, California Life Sciences’ Andrew Setikas interviews Devendra Mishra, Executive Director & Co-Founder of Bio Supply Management Alliance (BSMA). They share how government, industry, and trade..

Read More

Aequor redefines what ‘supply chain’ means during crisis

Dec 13, 2021

As a small biotech company, Aequor needs a reliable supply of chemicals and supplies. They lease lab space in an incubator setting. And in that lab, they develop custom product..

Read More

Nano PharmaSolutions will opt for air freight as their new tech floats in Los Angeles harbor

Dec 13, 2021

Nano PharmaSolutions (NPS) developed an enabling technology to improve the solubility of small molecule drugs for both new chemical compounds and already approved drugs. Its unique nanosizing method involves evaporating..

Read More

Catalent’s New Normal: How COVID-19 impacted the Supply Chain

Dec 13, 2021

Featured Expert: Melissa Buchanan, Director, Supply Chain, Catalent Biologics  The pandemic has touched almost every aspect of our lives, and the pharmaceutical industry had to adapt quickly to continue to..

Read More